Celldex Therapeutics, Inc.

DB:TCE2 Stock Report

Market Cap: €2.2b

Celldex Therapeutics Management

Management criteria checks 2/4

Celldex Therapeutics' CEO is Anthony Marucci, appointed in May 2003, has a tenure of 20.92 years. total yearly compensation is $8.36M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 0.044% of the company’s shares, worth €974.02K. The average tenure of the management team and the board of directors is 7.8 years and 11.2 years respectively.

Key information

Anthony Marucci

Chief executive officer

US$8.4m

Total compensation

CEO salary percentage8.6%
CEO tenure20.9yrs
CEO ownership0.04%
Management average tenure7.8yrs
Board average tenure11.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Anthony Marucci's remuneration changed compared to Celldex Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$8mUS$721k

-US$141m

Sep 30 2023n/an/a

-US$125m

Jun 30 2023n/an/a

-US$113m

Mar 31 2023n/an/a

-US$119m

Dec 31 2022US$5mUS$693k

-US$112m

Sep 30 2022n/an/a

-US$106m

Jun 30 2022n/an/a

-US$100m

Mar 31 2022n/an/a

-US$77m

Dec 31 2021US$6mUS$669k

-US$71m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$66m

Mar 31 2021n/an/a

-US$64m

Dec 31 2020US$3mUS$644k

-US$60m

Sep 30 2020n/an/a

-US$48m

Jun 30 2020n/an/a

-US$46m

Mar 31 2020n/an/a

-US$46m

Dec 31 2019US$1mUS$619k

-US$51m

Sep 30 2019n/an/a

-US$50m

Jun 30 2019n/an/a

-US$46m

Mar 31 2019n/an/a

-US$50m

Dec 31 2018US$1mUS$608k

-US$151m

Sep 30 2018n/an/a

-US$146m

Jun 30 2018n/an/a

-US$165m

Mar 31 2018n/an/a

-US$177m

Dec 31 2017US$2mUS$598k

-US$93m

Compensation vs Market: Anthony's total compensation ($USD8.36M) is above average for companies of similar size in the German market ($USD1.62M).

Compensation vs Earnings: Anthony's compensation has increased whilst the company is unprofitable.

CEO

Anthony Marucci (61 yo)

20.9yrs

Tenure

US$8,361,844

Compensation

Mr. Anthony S. Marucci, M.B.A., has been the Chief Executive Officer and President of Celldex Therapeutics Inc. since September 2008. He co-founded Celldex Therapeutics Inc. in 2004. Mr. Marucci served as...

Leadership Team

NamePositionTenureCompensationOwnership
Anthony Marucci
Founder20.9yrsUS$8.36m0.044%
$ 974.0k
Tibor Keler
Founder20.9yrsUS$3.42m0.011%
$ 255.4k
Sam Martin
Senior VP6.8yrsUS$2.95m0.055%
$ 1.2m
Margo Heath-Chiozzi
Senior Vice President of Regulatory Affairs6.5yrsUS$2.94m0.018%
$ 409.5k
Diane Young
Senior VP & Chief Medical Officer4.8yrsUS$2.97m0.073%
$ 1.6m
Joseph Schlessinger
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Sarah Cavanaugh
Senior Vice President of Corporate Affairs & Administration6.8yrsno data0.0020%
$ 44.5k
Freddy Jimenez
Senior VP & General Counsel3.3yrsUS$2.17m0.040%
$ 900.0k
Ronald Pepin
Chief Business Officer & Senior VP12.8yrsno datano data
Elizabeth Crowley
Chief Product Development Officer & Senior VP9.8yrsUS$1.18mno data
Richard Wright
Chief Commercial Officer & Senior VP8.8yrsUS$563.17k0.00032%
$ 7.2k

7.8yrs

Average Tenure

61yo

Average Age

Experienced Management: TCE2's management team is seasoned and experienced (7.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Anthony Marucci
Founder15.3yrsUS$8.36m0.044%
$ 974.0k
Joseph Schlessinger
Co-Founder & Member of Scientific Advisory Board2.7yrsno datano data
Harry Penner
Independent Director27.3yrsUS$371.19k0.0043%
$ 96.8k
Herbert Conrad
Independent Director16.1yrsUS$364.94k0.0040%
$ 89.0k
Louis Weiner
Member of Scientific Advisory Boardno datano datano data
James Marino
Independent Director7.1yrsUS$377.44k0.020%
$ 441.0k
Karen Shoos
Independent Chair of the Board of Directors22.9yrsUS$385.77k0.0043%
$ 96.6k
Carl June
Member of Scientific Advisory Boardno datano datano data
Michel Nussenzweig
Member of Scientific Advisory Boardno datano datano data
Marc Rothenberg
Member of Scientific Advisory Boardno datano datano data
Keith Brownlie
Independent Director6.8yrsUS$373.27k0.0010%
$ 23.0k
Cheryl Cohen
Independent Director1.8yrsUS$367.02kno data

11.2yrs

Average Tenure

71yo

Average Age

Experienced Board: TCE2's board of directors are seasoned and experienced ( 11.2 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.